Philips launches QuickClear mechanical thrombectomy system for blood clot removal in latest portfolio expansion

17744

Royal Philips has announced the launch of the QuickClear mechanical thrombectomy system. The single-use system delivers an all-in-one aspiration pump and catheter to remove blood clots from the vessels of the peripheral arterial and venous systems and has received US Food and Drug Administration (FDA) 510(k) clearance.

The system’s design aims to simplify the use of the device and improve procedure times without the need for capital equipment or accessories.

Chris Landon, senior vice president and general manager of image guided therapy devices at Philips claims that “by taking away the high initial capital expenditure costs associated with traditional mechanical thrombectomy systems, QuickClear can help bring cost-effective solutions to both the hospital and outpatient care settings.”

The small footprint of the sterile device allows it to be placed easily on the table next to the patient. The company claims that the system can easily work at maximum aspiration power within seconds and that the consistency of the aspiration power during the procedure supports faster procedure times.

Furthermore, the system’s range of catheters includes a large 10F aspiration catheter which, according to the company’s own in-house data, provides 59% more aspiration volume than 8F aspiration catheters.

Bryan Fisher (Nashville, USA) says that the “QuickClear is a simple and easy to use mechanical thrombectomy system.” He adds that it “is significantly smaller than other systems without compromising aspiration power.

The QuickClear mechanical thrombectomy system is the latest expansion of the company’s portfolio after acquiring Intact Vascular. Philips’ peripheral vascular portfolio already includes advanced interventional imaging systems for precision guidance; intravascular ultrasound (IVUS) catheters to assess the location of the disease and lesion morphology and guide and confirm the treatment; peripheral atherectomy devices to remove blockages; and peripheral therapy devices, such as Philips’ Stellarex drug-coated balloon, to treat lesions.


LEAVE A REPLY

Please enter your comment!
Please enter your name here